Somatropin biosimilar (SICOR Biotech UAB)

生长激素生物类似药 (SICOR Biotech UAB)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSomatropin biosimilar (SICOR Biotech UAB)
Drug Alias Name生长激素生物仿制药 (SICOR Biotech UAB)Somatogen-L
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiency
Global Approved IndicationsGrowth hormone deficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryLithuania
Original Approved Date1994/01/01
Country/TerritoryLithuania
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTeva Pharmaceutical Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTeva Pharmaceutical Industries Ltd
Inactive CompaniesN/A
Active IndicationsGrowth hormone deficiency
Inactive IndicationsN/A

Other Information

ATC CodeH01AC01
Related LinksN/A